Synendos Therapeutics Appoints Scientific Advisory Board
Synendos Therapeutics is thrilled to announce the formation of the Scientific Advisory Board composed of prominent scientists and clinicians with significant CNS expertise. Read more
Tag Archive for: biotech
Destiny Pharma: Major US hospital-based clinical trial highlights benefit of nasal decolonization to reduce ICU infections caused by Staphylococcus aureus
Major US hospital-based clinical trial highlights benefit of nasal decolonization to reduce ICU infections caused by Staphylococcus aureus Strong support for potential of XF-73 nasal product as alternative to mupirocin Brighton, United Kingdom – 18 October 2021 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the development of novel medicines to prevent life […]
6th Annual LSX Investival Showcase
8-15 NOV 2021 | Hybrid
LSX Food Biotech Congress 2021
8-12 NOV 2021 | Hybrid
Investor Q&A Series: Roel Bulthuis, INKEF Capital
In our first Investor Q&A article, Roel Bulthuis, Managing Partner of INKEF Capital shares his thoughts on the investment landscape in Europe.
